Outlook Therapeutics, Inc.
USD1.69
-0.02 (-1.17%)
CEO
Robert Charles Jahr
IPO Date
2016-06-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.72
Prev. Close
$1.71
Day Low
$1.62
Day High
$1.77
52W Low
$0.16
52W High
$3.39
Market Cap
$0.07B
Volume
7.73M
| 8,539,709 |
| $0.59 |
| 1 Jun 2026 | Sukhtian Ghiath M. | director, 10 percent owner: | H-ExpireLong | Disposed | 3,458,571 | $2.26 |
| 1 Jun 2026 | Sukhtian Ghiath M. | director, 10 percent owner: | P-Purchase | Acquired | 3,458,571 | $0.59 |
| 1 Jun 2026 | Sukhtian Ghiath M. | director, 10 percent owner: | H-ExpireLong | Disposed | 8,571,428 | $1.40 |
| 1 Jun 2026 | Sukhtian Ghiath M. | director, 10 percent owner: | P-Purchase | Acquired | 8,571,428 | $0.59 |
| 27 May 2026 | Sukhtian Faisal Ghiath | director | P-Purchase | Acquired | 122,174 | $0.41 |
| 27 May 2026 | Haddadin Yezan Munther | director | P-Purchase | Acquired | 34,000 | $0.44 |
| 27 May 2026 | THURMAN RANDY H | director | P-Purchase | Acquired | 5,000 | $0.43 |
| 27 May 2026 | HILZINGER KURT J | director | P-Purchase | Acquired | 400,000 | $0.44 |